Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
ImmunoCellular Therapeutics Ltd logo — Pioneering immune-based therapies to harness the body's defe...

ImmunoCellular Therapeutics Ltd

Pioneering immune-based therapies to harness the body's defenses against cancer through advanced immunotherapy development.

Founded 2006 United States Calabasas, United States 11 employees Grant Total: $32.47M Biotechnology, Health Care

General Information

Company Name ImmunoCellular Therapeutics Ltd
Founded Year 2006
Location United States Calabasas, United States +1
Employees 11
Industries Biotechnology, Health Care
Funding Stage Grant
Social

Get notified when ImmunoCellular Therapeutics Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ImmunoCellular Therapeutics Ltd

ImmunoCellular Therapeutics is a biotechnology firm pioneering immune-based therapies to harness the body's defenses against cancer through advanced immunotherapy development. Founded in 2006, the company focuses on creating immune-based treatments for cancers. Its flagship product, ICT-107, is a dendritic cell (DC) immunotherapy designed to treat newly diagnosed glioblastoma multiforme (GBM), a highly aggressive brain cancer. This approach involves stimulating a patient's immune system to target tumor antigens, which are molecular signals used by the immune system to identify foreign bodies. In September 2015, ImmunoCellular Therapeutics secured a significant $19.90M grant investment from the California Institute for Regenerative Medicine. This funding showcased confidence in the potential of the company's immunotherapy technology. ImmunoCellular Therapeutics operates in the biotechnology and healthcare sectors, positioning itself at the intersection of innovative medical advancements and addressing critical oncological needs. Their groundbreaking approach to immunotherapy development holds promise for revolutionizing cancer treatment and making significant strides in improving patient outcomes.

Taxonomy: ImmunoCellular Therapeutics, immune-based therapies, immunotherapy development, cancer treatment, clinical-stage, ICT-107, dendritic cell immunotherapy, glioblastoma multiforme, brain cancer, immune system stimulation, tumor antigens, immune response, cancer immunotherapy, patient-specific treatment

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 24 Sep 2015
Venture Round •••••• 1
Investor
11 Mar 2011
Venture Round •••••• - 02 Jun 2010
Venture Round •••••• - 12 Apr 2010

ImmunoCellular Therapeutics Ltd Alternatives & Competitors

ImmunoCellular Therapeutics Ltd vs
OXVax Ltd
OXVax Ltd United Kingdom

Developing a Next Generation Cancer Vaccine

Seed
2-10 employees
Biotechnology, Health and Wellness
ImmunoCellular Therapeutics Ltd vs
Caedo Oncology AS
Caedo Oncology AS Norway

We create improved treatment options for cancer patients through unique immunotherapy opportunities

Series Unknown
6 employees
Biotechnology, Health Care
ImmunoCellular Therapeutics Ltd vs
Duet BioTherapeutics
Duet BioTherapeutics United States

A Scopus BioPharma company creating targeted immunotherapies for treatment-resistant cancers.

Series Unknown
2 employees
Biopharma, Biotechnology

FAQ About ImmunoCellular Therapeutics Ltd

Pioneering immune-based therapies to harness the body's defenses against cancer through advanced immunotherapy development.
ImmunoCellular Therapeutics Ltd was founded in 2006.
ImmunoCellular Therapeutics Ltd is headquartered in Calabasas, United States.
ImmunoCellular Therapeutics Ltd operates in the following industries: Biotechnology, Health Care.
ImmunoCellular Therapeutics Ltd has approximately 11 employees.
ImmunoCellular Therapeutics Ltd has completed 4 funding rounds, raising a total of $32.47M. The latest funding stage is Grant.
Top alternatives and competitors to ImmunoCellular Therapeutics Ltd include OXVax Ltd, Caedo Oncology AS, Duet BioTherapeutics, Denvax , Immunowake, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ImmunoCellular Therapeutics Ltd and OXVax Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ImmunoCellular Therapeutics Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy